Page 3 of Glenmark Pharmaceuticals

Glenmark Pharma, Glenmark Pharma Q2 results, profit, loss, revenue, EBITDA, legal settlement, expenses, branded formulations, domestic business

USFDA grants approval to Glenmark’s generic formulation to treat schizophrenia

According to IQVIA TM sales data for the 12-month period ending September 2023, the Prolixin Tablets, 1 mg, 2.5 mg,…

November 7, 2023 11:31 IST

Glenmark Pharmaceuticals, Diabetes, Type 2 Diabetes, fixed dose combination, healthcare news,

Glenmark launches triple drug formulation for type 2 diabetes patients in India

Glenmark’s Zita portfolio of medicines has been benefiting around 1.75 million Type 2 diabetic patients annually, in India.

October 18, 2023 11:11 IST

USFDA gives final nod to Glenmark’s psoriasis drug

It is a medication for the treatment of certain types of psoriasis and psoriatic arthritis.

October 17, 2023 12:25 IST

Glenmark’s subsidiary Ichnos Sciences enters into licensing agreement with Astria Therapeutics for its monoclonal antibody portfolio

With the execution of this agreement, Ichnos has successfully licensed its two assets for inflammatory and immunological diseases, a key…

October 12, 2023 11:12 IST

Expect gains from the Nirma deal on our books from FY25 & fruits from innovation play from FY27: Glenn Saldanha

“What this transaction does is that it helps both the companies achieve their long-term strategic goal in the best way…

September 22, 2023 15:41 IST

Glenmark, Glenmark pharmaceuticals, diabetes, blood sugar, healthcare news, pharma news,

Glenmark Pharmaceuticals gets ANDA approval for its anti-diabetic drug

According to the company’s press statement, the generic version of Onglyza Tablets, 2.5 mg and 5 mg, of AstraZeneca AB.

August 1, 2023 11:43 IST

Glenmark Pharma, breast cancer, pharma, Trastuzumab, healthcare, cancer, drug

Glenmark Pharma slashes price of breast cancer drug Trastuzumab

“The new price of the drug being marketed under the brand name ‘Trumab’, will be Rs 15,749 per 440 mg…

Updated: June 16, 2023 13:08 IST

Glenmark Pharmaceuticals, glenmark pharma, healthcare news, pharma news,

Glenmark Pharmaceuticals receives ANDA approval for its psychosis tablets

According to IQVIA TM sales data for the 12-month period ending January 2023, the Compazine Tablets, 5 mg and 10…

March 20, 2023 15:17 IST

USFDA accepts Glenmark’s application to initiate human trial of molecule for advanced solid tumors and lymphomas

GRC 54276 is an orally available, small-molecule hematopoietic progenitor kinase 1 (HPK1) inhibitor developed by Glenmark.

March 16, 2023 17:01 IST

USFDA approves Glenmark Pharmaceuticals’ bacterial infection capsules

According to IQVIATM sales data for the 12-month period ending January 2023, the Cleocin Hydrochloride Capsules, 75 mg, 150 mg,…

March 14, 2023 12:47 IST

Glenmark and Cediprof announce exclusive distribution agreement in US

According to a press statement, Glenmark expects to commence distribution of the product in the U.S. during the second half…

March 9, 2023 09:25 IST

Glenmark Pharmaceuticals receives second ANDA tentative approval for blood-sugar-lowering tablets

Glenmark’s first tentative approval letter for Saxagliptin Tablets, 2.5 mg, and 5 mg was received on June 12, 2017.

February 19, 2023 13:29 IST

Glenmark Pharma reports revenue growth of 9.2 percent, PAT of 21.3 percent YoY in Q3FY23

Meanwhile, consolidated profit before tax jumped 37.3% to Rs 471 crore in Q3 FY23 from Rs 343.04 crore in Q3…

February 14, 2023 12:11 IST

Glenmark Pharmaceuticals, chemotherapy, anti-cancer drug, cancer treatment, healthcare news, pharma news,

Glenmark launches injection to prevent chemotherapy-induced nausea and vomiting in India

The drug is already being marketed in the EU, the US, and Australia.

January 23, 2023 11:23 IST

stocks in focus, stocks to watch, stocks in news, ITC

ITC, ICICI Lombard, Glenmark Pharma, Tata Metaliks, Delta Corp, RVNL, IndusInd Bank stocks in focus

Indian benchmark indices BSE Sensex, NSE Nifty 50 stare at a muted start amid mixed global cues. ITC, Glenmark Pharma,…

Updated: January 18, 2023 08:16 IST

Glenmark launches generic version of Novartis’ heart failure drug in India

The ARNI market (sacubitril + valsartan) is estimated to be Rs. 514 Crore; with an annual growth of 37.2%.

January 17, 2023 13:27 IST

Glenmark Pharmaceuticals launches congestive heart failure injection in United States

Bumetanide is used to reduce extra fluid in the body (edema) caused by conditions such as congestive heart failure, liver…

January 10, 2023 12:14 IST

Glenmark, Glenmark Pharmaceuticals, Type 2 Diabetes, fixed-dose combination, health news, pharma news,

Glenmark becomes first company to launch triple fixed-dose combination for type 2 diabetes in India

Earlier this year, Glenmark also launched Sitagliptin (Sitazit) and its FDCs, followed by Lobeglitazone (LOBG) and FDCs of Teneligliptin including…

Updated: December 21, 2022 17:41 IST

Related News

Florida Governor Hopeful James Fishback Vows to “Fire Every H‑1B” in State Agencies

‘ll fire every H-1B worker’: Florida Governor hopeful pledges to incentivise firms to hire Americans

Aadhaar Card Update: Simple step-by-step guide to change your address online without hassle

Aadhaar Card Update: How to change address in Aadhaar Card online in simple steps

New rent rules 2025: Mandatory online registration, limited deposits – Here’s all you need to know

Ajay Devgn and Kajol’s luxurious 5BHK Goa villa

Step inside Ajay Devgn–Kajol’s lavish 5BHK villa: Luxury pool, stunning interiors and a 100-year-old well

Indians among largest group to leave UK amid migration drop

74,000 Indians leave UK as net migration drops 80%, skilled worker visas plunge

Mcap of 7 of top-10 most valued firms climbs by Rs 96,201 crore

Market26 min ago

Last week, the combined market valuation of seven of the top-10 most valued firms saw a rise of Rs 96,200.95 crore, with Reliance Industries and Bajaj Finance leading the gains. The BSE benchmark also climbed, reaching a record high on Thursday. However, Bharti Airtel, TCS, and LIC faced a decline in their valuations, while Reliance Industries remained the top-ranked firm.

View all shorts

Photo Gallery

Dharmendra passes away at 89: A look back at his iconic roles

6 days agoNovember 24, 2025

View All

Page 3 of Glenmark Pharmaceuticals

Related News

Photo Gallery

Dharmendra passes away at 89: A look back at his iconic roles

Trending Topics